These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30647873)

  • 1. Fluorescent humanized anti-CEA antibody specifically labels metastatic pancreatic cancer in a patient-derived orthotopic xenograft (PDOX) mouse model.
    Lwin TM; Miyake K; Murakami T; DeLong JC; Amirfakhri S; Filemoni F; Yoon SN; Yazaki PJ; Shivley JE; Datnow B; Clary BM; Hoffman RM; Bouvet M
    Oncotarget; 2018 Dec; 9(99):37333-37342. PubMed ID: 30647873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Patient-Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti-CEA Antibody.
    Cox KE; Turner MA; Lwin TM; Amirfakhri S; Kelly KJ; Hosseini M; Ghosh P; Obonyo M; Hoffman RM; Yazaki PJ; Bouvet M
    Ann Surg Oncol; 2024 Sep; 31(9):6291-6299. PubMed ID: 38888861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid tumor-labeling kinetics with a site-specific near-infrared anti-CEA nanobody in a patient-derived orthotopic xenograft mouse model of colon cancer.
    Lwin TM; Turner MA; Amirfakhri S; Nishino H; Debie P; Cosman BC; Hoffman RM; Hernot S; Bouvet M
    J Surg Oncol; 2021 Dec; 124(7):1121-1127. PubMed ID: 34309885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescent Anti-MUC5AC Brightly Targets Pancreatic Cancer in a Patient-derived Orthotopic Xenograft.
    Turner MA; Hollandsworth HM; Nishino H; Amirfakhri S; Lwin TM; Lowy AM; Kaur S; Natarajan G; Mallya K; Hoffman RM; Batra SK; Bouvet M
    In Vivo; 2022; 36(1):57-62. PubMed ID: 34972700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Near-infrared-conjugated humanized anti-carcinoembryonic antigen antibody targets colon cancer in an orthotopic nude-mouse model.
    DeLong JC; Murakami T; Yazaki PJ; Hoffman RM; Bouvet M
    J Surg Res; 2017 Oct; 218():139-143. PubMed ID: 28985840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photoimmunotherapy Inhibits Tumor Recurrence After Surgical Resection on a Pancreatic Cancer Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model.
    Hiroshima Y; Maawy A; Zhang Y; Guzman MG; Heim R; Makings L; Luiken GA; Kobayashi H; Tanaka K; Endo I; Hoffman RM; Bouvet M
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S1469-74. PubMed ID: 25893411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) nude mouse model is inhibited by neoadjuvant chemotherapy in combination with fluorescence-guided surgery with an anti-CA 19-9-conjugated fluorophore.
    Hiroshima Y; Maawy A; Zhang Y; Murakami T; Momiyama M; Mori R; Matsuyama R; Katz MH; Fleming JB; Chishima T; Tanaka K; Ichikawa Y; Endo I; Hoffman RM; Bouvet M
    PLoS One; 2014; 9(12):e114310. PubMed ID: 25463150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-specific near-infrared nanobody probe rapidly labels tumors in an orthotopic mouse model of pancreatic cancer.
    Lwin TM; Hernot S; Hollandsworth H; Amirfakhri S; Filemoni F; Debie P; Hoffman RM; Bouvet M
    Surgery; 2020 Jul; 168(1):85-91. PubMed ID: 32370916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model.
    Metildi CA; Kaushal S; Luiken GA; Talamini MA; Hoffman RM; Bouvet M
    J Surg Oncol; 2014 Apr; 109(5):451-8. PubMed ID: 24249594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humanized Anti-Carcinoembryonic Antigen Antibodies Brightly Target and Label Gastric Cancer in Orthotopic Mouse Models.
    Cox KE; Turner MA; Amirfakhri S; Lwin TM; Hosseini M; Ghosh P; Obonyo M; Murakami T; Hoffman RM; Yazaki PJ; Bouvet M
    J Surg Res; 2024 Jan; 293():701-708. PubMed ID: 37839102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore.
    Lwin TM; Murakami T; Miyake K; Yazaki PJ; Shivley JE; Hoffman RM; Bouvet M
    Ann Surg Oncol; 2018 Apr; 25(4):1079-1085. PubMed ID: 29372363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly Selective Targeting of Pancreatic Cancer in the Liver with a Near-Infrared Anti-MUC5AC Probe in a PDOX Mouse Model: A Proof-of-Concept Study.
    Turner MA; Cox KE; Neel N; Amirfakhri S; Nishino H; Clary BM; Hosseini M; Natarajan G; Mallya K; Mohs AM; Hoffman RM; Batra SK; Bouvet M
    J Pers Med; 2023 May; 13(5):. PubMed ID: 37241027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescent Anti-CEA Nanobody for Rapid Tumor-Targeting and Imaging in Mouse Models of Pancreatic Cancer.
    Lwin TM; Turner MA; Nishino H; Amirfakhri S; Hernot S; Hoffman RM; Bouvet M
    Biomolecules; 2022 May; 12(5):. PubMed ID: 35625638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful fluorescence-guided surgery on human colon cancer patient-derived orthotopic xenograft mouse models using a fluorophore-conjugated anti-CEA antibody and a portable imaging system.
    Hiroshima Y; Maawy A; Metildi CA; Zhang Y; Uehara F; Miwa S; Yano S; Sato S; Murakami T; Momiyama M; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
    J Laparoendosc Adv Surg Tech A; 2014 Apr; 24(4):241-7. PubMed ID: 24494971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hand-held high-resolution fluorescence imaging system for fluorescence-guided surgery of patient and cell-line pancreatic tumors growing orthotopically in nude mice.
    Hiroshima Y; Maawy A; Sato S; Murakami T; Uehara F; Miwa S; Yano S; Momiyama M; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
    J Surg Res; 2014 Apr; 187(2):510-7. PubMed ID: 24373959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence-guided surgery with a fluorophore-conjugated antibody to carcinoembryonic antigen (CEA), that highlights the tumor, improves surgical resection and increases survival in orthotopic mouse models of human pancreatic cancer.
    Metildi CA; Kaushal S; Pu M; Messer KA; Luiken GA; Moossa AR; Hoffman RM; Bouvet M
    Ann Surg Oncol; 2014 Apr; 21(4):1405-11. PubMed ID: 24499827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved antibody-guided surgery with a near-infrared dye on a pegylated linker for CEA-positive tumors.
    Yazaki P; Lwin T; Minnix M; Li L; Sherman A; Molnar J; Miller A; Frankel P; Chea J; Poku E; Bowles N; Hoffman R; Shively J; Bouvet M
    J Biomed Opt; 2019 Jun; 24(6):1-9. PubMed ID: 31254333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NIR-II fluorescence imaging-guided colorectal cancer surgery targeting CEACAM5 by a nanobody.
    Guo X; Li C; Jia X; Qu Y; Li M; Cao C; Zhang Z; Qu Q; Luo S; Tang J; Liu H; Hu Z; Tian J
    EBioMedicine; 2023 Mar; 89():104476. PubMed ID: 36801616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Claudin-1 Conjugated to a Near-Infrared Fluorophore Targets Colon Cancer in PDOX Mouse Models.
    Hollandsworth HM; Lwin TM; Amirfakhri S; Filemoni F; Batra SK; Hoffman RM; Dhawan P; Bouvet M
    J Surg Res; 2019 Oct; 242():145-150. PubMed ID: 31077946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humanized Anti-Tumor-Associated Glycoprotein-72 for Submillimeter Near-Infrared Detection of Colon Cancer in Metastatic Mouse Models.
    Hollandsworth HM; Amirfakhri S; Filemoni F; Hoffman RM; Molnar J; Yazaki PJ; Bouvet M
    J Surg Res; 2020 Aug; 252():16-21. PubMed ID: 32217350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.